Pertuzumab and Trastuzumab Emtansine for Human Epidermal Growth Factor Receptor-2-Positive Metastatic Breast Cancer: Contemporary Population-Based Outcomes.
Robert B BasmadjianWinson Y CheungDouglas A StewartPublished in: Breast cancer : basic and clinical research (2019)
New anti-HER2 therapies appear to be clinically relevant in the real-world.